The global digital dentistry market in terms of revenue was estimated to be worth $7.2 billion in 2023 and is poised to reach $12.2 billion by 2028, growing at a CAGR of 10.9% from 2023 to 2028.
The prominent players in the digital dentistry market include Densply Sirona (US), Envista Holdings Corporation (US), 3M Company (US), Ivoclar Vivadent AG (Switzerland), Planmeca OY (Finland), 3Shape (Denmark), Align Technologies (US), J Morita Corporation (Japan), 3D Systems, Inc. (US), Straumann Group (Switzerland), Stratasys (US), Kulzer (US), Vatech Co. Ltd. (US), Carestream Dental LLC (US), Bego GMBH & Co. KG (Germany), Desktop Metal, Inc. (US), Roland DG Corporation (Japan), DWS Systems SRL (Italy), Midmark Corporation (US), Medit (South Korea), Sinol (China), Shandong Huge Dental Material Corporation (China), Planet DDS (US), GC Corporation (Japan), and Carima (South Korea).
To know about the assumptions considered for the study download the pdf brochure
Dentsply Sirona Inc. (US)
Dentsply Sirona Inc., one of the leading players in the digital dentistry market with a complete line of dental portfolio of products such as intraoral scanners with digital capabilities, CAD/CAM based restorations, and 3D priting equipment (scanners, printing device, and software). Densply Sirona is involved in the continuous innovations of their existing products to provide technologically improved solutions for healthcare and dental consumables. The company is located across the globe in regions of Germany, Sweden, UK, Switzerland, in most parts of Asia, North America, and MENA. The company’s heavy investments in its R&D sector to continuously build digitally advanced equipments, software and other accessories, along with its large distributors network across the globe, is expected to strengthen its position in the digital dentistry market. The company’s major strengths lie in its global presence, brand name, and wide product portfolio, including specialty products. It primarily focuses on inorganic strategies such as acquisition and expansion to maintain its position in the market. R&D is another important consideration for the company; it has pursued collaborations with external research institutions and dental & medical schools. Through its internal research centers and research collaborations, the company directly invests in developing products and improving its existing offerings.
Envista Holdings Corporation (US)
Envista Holdings Corporation is operated through two segments: Specialty Products & Technologies, which is comprised of Implants and Orthodontics businesses, and Equipment & Consumables, which is comprised of Imaging and Consumable businesses. The company’s strategies growth in terms of numerous acquisitions conducted over the past 25 years. Envista successfully acquired complete stakes of 25 leading dental businesses. Envista operates under 4 major brand names i.e, Dexis, Kerr, DTX, and Metrex, which are a part of its Speciality Products and Technologies segment. Operations are carried out in 125 + countries across Asia, EMEA, North America, and Southern and Latin America. Envista Holdings Corporation primarily focuses on product developments and launches to expand its footprint in the global market and carries out innovation as a core strategy to build its business. It had an R&D expenditure of USD 100.1 million in 2022. The company focuses on building strong partnerships to help it achieve its long-term growth targets. Envista plans to continue to invest in Greater China, which it perceives as a strong growth driver for its business in the future.
Planmeca OY (FINLAND)
The company operates through various segments, namely, Dental Units, Dental Imaging, Dental Software, CAD/CAM systems and software, and 3D and 2D imaging modalities. The company is headquartered in Finland, but holds a strong presence in over 120 regions, such as Turkey, Japan, Korea, etc. They have a wide distributorship network across 200+ entities. Planmeca’s R&D unit is continuously developing functional and durable products throught continued innovations and new product launches. Mergers and acquisitions has got the company to reach a strong mark in the dental industry. For instance, KaVo’s treatment unit was acquired by Planmeca in September 2021. strengthening Planmeca’s and KaVo’s positions as leading providers of innovative dental solutions and increasing the group’s annual revenue by more than EUR 1.1 billion.
Related Links:
